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Virus derived from an infectious cDNA clone of equine arteritis virus (EAV030H) was intranasally inoculated into two
stallions, neither of which subsequently developed clinical manifestations of equine viral arteritis (EVA). Virus was isolated
from nasal swabs and mononuclear cells collected from both stallions #14 days p.i. and from the semen of one stallion only
at 7 days p.i. Similarly, viral RNA was detected by RT nested-PCR in nasal swabs and mononuclear cells for #14 days p.i. and
at 7 days p.i. in the semen of the one stallion. Both stallions seroconverted to EAV by 10 days p.i. and maintained high
neutralizing antibody titers thereafter. Sequence and restriction digestion analysis demonstrated that the recombinant virus
present in nasal swabs, mononuclear cells, and semen from the two stallions was identical to the infectious clone-derived
virus that was used to inoculate them. Furthermore analysis of multiple clones derived by RT nested-PCR amplification from
several samples indicated that the recombinant EAV030H virus was stable during replication in horses. These studies
document for the first time that a recombinant virus derived from an infectious cDNA clone of a member of the order
Nidovirales is replication competent in animals, and the genetic stability of the recombinant virus during in vivo replication
indicates that it will be useful for the characterization of genetic determinants of virulence and persistence of EAV. The
genetic conservation of the cloned recombinant virus during in vivo infection is similar to that which occurs during natural
horizontal and vertical transmission of EAV in horses and contrasts with the heterogeneous virus population (quasispecies)
that occurs in the semen of carrier stallions. © 1999 Academic Press
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eINTRODUCTION
Equine arteritis virus (EAV), the causative agent of
quine viral arteritis (EVA) in horses, is distributed
hroughout the world, although the prevalence of infec-
ion varies between countries and horse breeds (McCol-
um and Bryans, 1973; Timoney and McCollum, 1993;
laser et al., 1997). EAV was first isolated from the lung
f an aborted fetus following an extensive outbreak of
espiratory disease and abortion on a Standardbred
reeding farm near Bucyrus, OH in 1953 (Doll et al.,
957). The consequences of EAV infection of horses
ange from subclinical infection to clinical disease char-
cterized by systemic influenza-like illness in adult
orses, abortion of pregnant mares, and interstitial pneu-
onia in neonatal foals (Timoney and McCollum, 1993;
laser et al., 1996, 1997). Some 60% of stallions infected
ith EAV subsequently become persistently infected car-
iers and play a critical role in maintenance and dissem-
nation of the virus (Timoney et al., 1987; Timoney and
cCollum, 1993). EAV persists in the reproductive tract of
1 To whom reprint requests should be addressed. Fax: (530) 754-
v124. E-mail: njmaclachlan@ucdavis.edu.
201he carrier stallion as a quasispecies of closely related
enomes (Hedges et al., 1999). We have recently dem-
nstrated that specific viral variants present in the se-
en of carrier stallions can initiate outbreaks of EVA
uring which the virus spreads by aerosol (Balasuriya et
l., 1999). In contrast to the heterogeneic viral population
resent in the semen of persistently infected stallions,
iruses that circulated during an outbreak of EVA were
elatively homogeneous (Balasuriya et al., 1999).
EAV is the prototype virus in the family Arteriviridae
genus Arterivirus, order Nidovirales), which also in-
ludes lactate dehydrogenase elevating virus of mice,
imian hemorrhagic fever virus, and porcine reproduc-
ive and respiratory syndrome virus (Cavanagh, 1997;
nijder and Meulenberg, 1998). EAV is an enveloped
ositive-stranded RNA virus. The EAV genome is
12,700 nucleotides in length with a 39 polyadenylated
ail and includes nine open reading frames [ORFs; 1a, 1b,
a, 2b, 3, 4, 5, 6, and 7 (den Boon et al., 1991; Snijder et
l., 1999)]. The ORFs 1a and 1b encode the viral replicase
den Boon et al., 1991; Snijder and Meulenberg, 1998).
RFs 2b, 5, and 6, respectively, encode the 25-kDa minor
nvelope glycoprotein (GS), the 30- to 42-kDa major en-
elope glycoprotein (GL), and the 17-kDa unglycosylated
0042-6822/99 $30.00
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202 BALASURIYA ET AL.nvelope protein (M). The GL envelope glycoprotein ex-
resses the known neutralization determinants of the
irus. It recently has been demonstrated that ORF2a
ncodes a 67-amino-acid unglycosylated structural pro-
ein (E) of EAV (Snijder et al., 1999). ORFs 3 and 4 are
redicted to encode membrane glycoproteins (GP3 and
P4) of unknown function. The ORF 7 encodes the 12-
Da nucleocapsid protein (N), which forms an icosahe-
ral core that encapsidates the genomic RNA.
There is only one serotype of EAV; however, geograph-
cally and temporally distinct EAV isolates differ substan-
ially in their phenotypic properties such as virulence and
eutralization determinants (Timoney and McCollum,
993; Balasuriya et al., 1997). Experimental infection
tudies with different strains have identified lentogenic
avirulent), mesogenic (moderately virulent), and velo-
enic (highly virulent) strains of EAV (McCollum and
werczek, 1978; McCollum and Timoney, 1984, 1998;
acLachlan et al., 1996; Patton et al., 1999). Previous
tudies have demonstrated that geographically and tem-
orally distinct strains of EAV also differ significantly in
heir structural protein genes (Balasuriya et al., 1995b,
999; Hedges et al., 1996, 1999; Patton et al., 1999). The
ignificance of such changes demonstrated in retrospec-
ive studies, however, can only be unequivocally estab-
ished with prospective genome manipulation using in-
ectious cDNA clones.
The genome of positive-stranded RNA viruses func-
ions as a mRNA from which viral proteins necessary for
irus replication are translated, thus in vitro RNA tran-
cripts from full-length cDNA clones of positive-stranded
NA viruses are infectious (Racaniello and Baltimore,
981; Boyer and Haenni, 1994). Infectious cDNA clones
f a number of animal and human viruses have been
eveloped, including an infectious cDNA clone of EAV
Rice et al., 1987; Sumiyoshi et al., 1992; Meyers et al.,
996; van Dinten et al., 1997; Meulenberg et al., 1998).
he full-length infectious clone of EAV provides a novel
ool to better characterize the replication, pathogenesis,
nd evolution of EAV. The objective of this study was to
etermine the pathogenicity and genetic stability in
orses of the virus derived from an infectious cDNA
lone developed from a highly cell culture-adapted lab-
ratory variant of the original Bucyrus strain of EAV.
RESULTS AND DISCUSSION
An immunofluorescence staining assay was per-
ormed to demonstrate the expression of EAV proteins in
ells transfected with the full-length in vitro RNA tran-
cripts derived from the infectious cDNA clone
pEAV030H; van Dinten et al., 1997). Immunofluores-
ence staining of BHK-21 cells 20–22 h after transfection
howed expression of nonstructural proteins nsp2 and
sp7–8, and of the GL and N structural proteins, suggest-ng that in vitro RNA transcripts were infectious to theransfected cells (data not shown). A virus stock made
rom the tissue culture supernatant of the transfected
ells was confirmed to be EAV by microneutralization
ssay using both EAV-specific neutralizing monoclonal
ntibodies and polyclonal equine antiserum (data not
hown). The identity of the virus derived from transfected
NA was unequivocally confirmed by amplification of a
01-bp segment (nucleotide 6590–7451) containing an
ngineered marker HindIII restriction site (nucleotide
umber 6973) in ORF 1b of the recombinant EAV030H
irus (Fig. 1; van Dinten et al., 1997).
The recombinant EAV030H virus derived from the in-
ectious cDNA clone was intranasally inoculated into two
tallions. Neither of the two stallions developed severe
linical manifestations of EVA, but both became mildly
ebrile and developed mild to moderate lymphopenia and
hrombocytopenia although there were no significant
hanges in their clotting parameters (Fig. 2). Virus was
solated from nasal swabs and mononuclear cells col-
ected from both stallions and from the semen of one
tallion (Table 1).
Viral RNA was detected by direct reverse transcription
nd nested PCR (RT nested-PCR) amplification of ORF5
rom nasal swab, mononuclear cell, serum, and semen
amples collected from the stallions (Table 1 and Fig.
E). The 901-bp segment containing the marker HindIII
estriction site in ORF 1b was also amplified by RT–PCR
rom the first tissue culture passage of virus isolated
rom both stallions [6 days p.i. nasal swab (stallion E) and
days p.i. buffy coat (stallion O); Fig. 1]. Digestion with
indIII showed that the marker restriction site in ORF1b
f the recombinant EAV030H virus was present in the
mplicon generated from each sample, thus confirming
hat the virus in the sample indeed was derived from the
ecombinant EAV030H virus that was used to inoculate
he two stallions.
FIG. 1. Restriction digestion analysis of the RT–PCR amplified 901-bp
egment containing the marker HindIII site in ORF1b of the recombi-
ant EAV030H virus. Lanes 1 and 3, respectively, contain the undi-
ested 901-bp segment from EAV030H virus and (as a representative
xample) the first tissue culture passage of EAV isolated from the nasal
wab collected from stallion E at 6 days p.i. Lanes 2, 4, and 5,
espectively, contain the HindIII digested 901-bp segment from the
riginal recombinant EAV030H, the first tissue culture passage of EAV
solated from the nasal swab collected from stallion E at 6 days p.i., and
rom the mononuclear cells collected from stallion O at 6 days p.i. Sizes
f the fragments are indicated on the left margin.EAV is not usually isolated beyond 28 days p.i. from
n
a
e
203CLONE-DERIVED EAV IS REPLICATION COMPETENTFIG. 2. Body temperature (A), hematological parameters [blood lymphocyte counts per microliter (B) and platelet counts per microliter (C)],
eutralizing antibody titers [(D); expressed as the reciprocal of the highest final dilution that provided $50% protection of the RK-13 cell monolayer],
nd presence (indicated by shaded boxes) or absence (indicated by open boxes) of virus (viremia) or viral RNA in the blood of stallions O and E after
xperimental inoculation with the recombinant EAV030H virus.
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204 BALASURIYA ET AL.nfected horses other than from the semen of persistently
nfected stallions. In this study, we did not demonstrate
ither infectious virus or viral RNA in nasal secretions or
lood after 14 days p.i. of the stallions (Table 1, Fig. 2E).
he minor discrepancies that occurred between virus
solation and RT nested-PCR results may be due to
ifferences in the original volume used for each assay (1
l vs. 140–500 ml of sample, respectively). The data
emonstrate that false negative results can occur with
T nested-PCR as compared with virus isolation, thus
esults should be carefully interpreted in any diagnostic
T nested-PCR assay. The patterns of viremia and asso-
iation of recombinant virus with blood mononuclear
ells were similar to those observed in horses that were
aturally or experimentally infected with other strains of
AV (McCollum et al., 1971; McCollum, 1981; Timoney
nd McCollum, 1993; McCollum and Timoney, 1984; Mac-
achlan et al., 1996). The recombinant virus failed to
stablish persistent infection in either stallion; however,
tallion O shed virus in semen at 7 days p.i. when it also
as viremic.
Both stallions seroconverted to EAV by 10 days p.i.,
nd titers of neutralizing antibody in their serum in-
reased to 256 by 42 days p.i. in stallion O and to 64 by
4 days p.i. in stallion E and remained constant thereaf-
er (Fig. 2D). The clearance of virus from blood mononu-
lear cells coincided with the appearance of neutralizing
ntibodies (Figs. 2D and 2E).
EAV strains vary significantly in their pathogenicity.
he majority of field strains cause subclinical or inappar-
nt infection, whereas some strains cause obvious clin-
cal signs of EVA (Timoney and McCollum, 1993; Glaser
t al., 1996; McCollum and Timoney, 1998). The patho-
enesis of EVA has been characterized by inoculation of
orses with virulent and avirulent strains of EAV by the
T
Virus Isolation and Detection of Viral RNA in Samples Collec
Method Sample name
Stallion O (Days posti
0 2 4 6 7 8
irus isolation Nasal swabs 2* 1 1 1 NC 1
Mononuclear cells 2* 1 1 1 NC 1
Serum 2* 2 2 2 NC 2
Plasma 2* 2 2 2 NC 2
Semen 2* NC NC NC 1 NC
T-Nested PCR Nasal swabs 2* 1** 1 1 NC 1
Mononuclear cells 2* 2 2 1** NC 1
Serum 2* 2 1 1 NC 2
Plasma 2* 2 2 2 NC 2
Whole blood 2* 2 2 2 NC 2
Semen 2* NC NC NC 1** NC
* Preinoculation sample, ** Samples also used for direct sequencin
solation or RT nested-PCR negative.ntranasal, intramuscular, or intravenous routes, as well us by careful evaluation of natural outbreaks of EVA
McCollum, 1970; McCollum et al., 1971, 1995, 1998; 1981;
imoney, 1984; Glaser et al., 1996). These studies have
dentified lentogenic, mesogenic, and velogenic strains
f EAV (McCollum and Timoney, 1998). The highly virulent
BS53 strain of EAV was derived by serial passage of the
riginal Bucyrus strain of EAV in horses (McCollum and
imoney, 1998). The VBS53 virus is considered the pro-
otype strain of EAV and causes severe clinical disease
r death in inoculated horses (MacLachlan et al., 1996;
cCollum and Timoney, 1998). Most of the available EAV
aboratory strains, including EAV030H, are derived from
his highly virulent virus. The parent virus of recombinant
AV030H was passaged extensively in cell culture and
loned by end point dilution and plaque purification in
frican green monkey cells (Vero cells), prior to propa-
ation of the working virus stocks. Viral RNA from this
ighly cell culture adapted laboratory strain of EAV was
sed to generate the genomic cDNA library that was
sed construct the infectious cDNA clone of EAV. Exper-
mental infection of two stallions with the recombinant
AV030H virus derived from this infectious cDNA clone
ed to subclinical infection, which indicates that an at-
enuated virus was selected during cell culture passage
r during construction of the recombinant virus based on
he consensus sequence derived from the cDNA library.
lternatively, the plaque purification and cell culture
ropagation likely subjected the original virus to a bot-
leneck leading to the selection of an attenuated variant.
We previously have shown that ORF 5 is the most
ariable structural protein gene of EAV (Balasuriya et al.,
995; Hedges et al., 1996). To determine the genetic
ariability of the recombinant virus following infection,
he master sequence of the virus directly amplified from
he EAV030H tissue culture fluid (that was used to inoc-
r Inoculation of Stallions with Recombinant EAV 030H Virus
tion) Stallion E (Days postinoculation)
12 14 21 0 2 4 6 7 8 10 12 14 21
2 1 2 2 1 1 1 NC 2 2 2 2 2
2 1 2 1 1 1 NC 2 2 2 2 2
2 2 2 2 2 2 2 NC 2 2 2 2 2
2 2 2 2 2 2 2 NC 2 2 2 2 2
NC 2 2 2* NC NC NC 2 NC NC NC 2 2
1 1** 2 2 1** 1 2 NC 2 2 2 1** 2
1 1** 2 2 2 2 1** NC 1 1** 2 2 2
2 2 2 2 2 2 2 NC 1 2 2 2 2
2 2 2 2 2 2 2 NC 2 2 2 2 2
2 2 2 2 2 2 2 NC 2 2 2 2 2
NC 2 2 2* NC NC NC 2 NC NC NC 2 2
Not collected. 1, virus isolation or RT nested-PCR positive; 2, virusABLE 1
ted afte
nocula
10
2
1
2
2
NC
1
1
2
2
2
NC
g. NC,late the two stallions) as well as those from the nine
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205CLONE-DERIVED EAV IS REPLICATION COMPETENTamples collected during the course of infection of the
wo stallions was determined by cycle sequencing (Table
). Sequence analysis of ORF5 demonstrated that eight
f nine master sequences of viruses present in the dif-
erent samples were identical to that of the original 030H
irus, whereas that of one virus (6 days p.i. buffy coat
rom stallion E) differed by just one nucleotide at position
1859 (C3T). The nucleotide substitution was noncod-
ng, and the amino acid sequences of all GL proteins
ere identical. Thus sequence analysis of ORF5 and
estriction analysis of ORF 1b demonstrated that the
ecombinant virus recovered from nasal swabs, mono-
uclear cells, and semen of the two stallions was iden-
ical to the original cloned virus that was used to inocu-
ate them, which clearly indicates that the recombinant
irus derived from the infectious cDNA clone of EAV was
table during replication in the two stallions.
RNA virus genomes are prone to error due to the lack
f proofreading-repair activities and low fidelity of their
NA replicases and transcriptases (Domingo et al.,
985). Therefore RNA virus populations do not consist of
single genome species with a single sequence but
ather of heterogeneous mixtures of related genomes
nown as a viral quasispecies. We previously have dem-
nstrated that EAV behaves as a quasispecies in the
eproductive tract of the carrier stallion (Balasuriya et al.,
999; Hedges et al., 1999). To investigate the generation
f viral variants following in vivo replication of the
AV30H virus, the ORF 5 sequence of 80 clones derived
y direct RT nested-PCR from various samples were
ompared. These included 20 clones from the original
30H virus derived from the RNA-transfected cell culture
luid and 40 clones from two mononuclear cell samples
stallion O: 14 days p.i., stallion E: 8 days p.i.; 20 each)
nd 20 clones from the single semen sample (stallion O:
days p.i.). To reduce artifactual substitutions, the PCR
mplification reactions were carried out with the high-
idelity Pfu DNA polymerase enzyme (Stratagene; Smith
t al., 1997). The sequences of 60 of the 80 clones (75%)
ere identical to that of the original EAV030H virus.
ixteen of the clones had a single nucleotide change,
nd 4 clones had two changes. The majority of the
hanges in these clones were transitional (22/24) and
andomly scattered throughout ORF 5. Sequence differ-
nces in these clones included a unique transitional
hange (A3G) at nucleotide 11,365 in 11 clones from the
4 days p.i. mononuclear cell sample from stallion O.
ost changes were also nonsynonymous (22/24) but
onservative; however, three changes resulted in non-
onservative amino acid changes in the GL protein (non-
olar to uncharged polar [amino acid 124 F to Y and 213
to S] and basic to nonpolar [amino acid 39 R to L]).
verall, the data indicate that the recombinant EAV030H
irus derived from the infectious cDNA clone is stable
uring replication in vivo. The conserved nature of theecombinant virus is similar to that which occurs during catural horizontal and vertical transmission of EAV in
orses and contrasts markedly with the heterogeneous
irus population (quasispecies) that occurs in the semen
f carrier stallions (Balasuriya et al., 1999; Hedges et al.,
999).
In conclusion, recombinant EAV derived from the re-
ently developed infectious cDNA clone is attenuated
nd genetically stable during replication in vivo. These
tudies document for the first time that a recombinant
irus derived from an infectious cDNA clone of a member
f the order Nidovirales is replication competent in ani-
als. The genetic stability of this recombinant virus dur-
ng in vivo replication indicates that it will be useful to the
haracterization of genetic determinants of virulence and
ersistence of EAV. The approach used to engineer this
lone now should be used to construct full-length infec-
ious clones of mesogenic and velogenic strains as well
s recombinant chimeric viruses of these strains of EAV.
evelopment of such recombinant chimeric clones from
ifferent EAV strains will facilitate characterization of
enetic determinants of critical phenotypic properties of
AV.
METHODS
ells and virus
Baby hamster kidney cells (BHK-21; ATCC CCL10)
ere maintained in Eagle’s medium (EMEM) supple-
ented with 10% fetal bovine serum (FBS; Hyclone Lab-
ratories Inc.), 10% tryptose phosphate broth, and 1%
enicillin and streptomycin. Rabbit kidney 13 (RK-13;
TCC CCL 37) cells were maintained in EMEM supple-
ented with 10% calf serum (CS; Hyclone Laboratories
nc.) and antibiotics. Full-length run off RNA transcripts
ere generated in vitro with modification to a previously
escribed protocol from XhoI-linearized pEAV030H plas-
id, which has an engineered marker HindIII site at
ucleotide 6973 in the ORF 1b region (van Dinten et al.,
997). Briefly, a 50-ml reaction containing 2 mg of linear-
zed plasmid DNA, RNA guard (37 U/ml; Pharmacia),
7G(59)PPP(59)G RNA cap structure analogue (New En-
land BioLabs), 5 ml of rATP, rCTP, rGTP, and rUTP (10
M mix), 2.5 ml of 100 mM DTT, 2.5 ml of T7 RNA
olymerase, and 13 transcription buffer (Promega) was
ncubated at 37°C for 1 h. The in vitro transcribed RNA
as stored at 280°C until use.
In vitro generated RNA transcripts were transfected
nto BHK-21 cells by electroporation. Briefly, BHK-21 cells
ere grown to subconfluence in regular growth medium,
nd the cells were trypsinized, washed, and resus-
ended in phosphate-buffered saline (PBS; pH 7.4) at a
oncentration of 1 3107 cells/ml. RNA transcript (;10–20
g) was added to 500 ml of BHK-21 cell suspension (5 3
06 cells) in an electroporation cuvette (0.2-cm electrode
ap; BioRad). Two pulses of 1500 V, infinity V (pulse
ontroller), and 25-mF capacitance were given with a
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206 BALASURIYA ET AL.ene Pulser II electroporator unit (BioRad). Cells were
ncubated at room temperature for 10 min after electro-
oration and mixed with 10–15 ml of complete BHK-21
edium warmed to room temperature. The cells were
eeded onto 10-cm-diameter tissue culture plates (Fal-
on) and incubated 37°C for 60 h until 100% cytopathic
ffect (CPE) was evident. Tissue culture fluid was har-
ested, centrifuged at 1600 g for 10 min at 4°C. The
upernatant was aliquoted into 1.5 ml tubes and stored at
80°C until use. The virus was designated as EAV030H,
nd titers were determined by both Reed and Munch
ethod [(Reed and Muench, 1938); 2.0 3 106.25 tissue
ulture infectious doses (TCID50)/50 ml] and plaque as-
ay (3.25 3 106 PFU/ml). For immunofluorescence as-
ays, electroporated BHK-21 cells were directly plated
nto chamber slides and incubated at 37°C for 20–22 h.
mmunofluorescence assays
Monospecific rabbit anti-peptide serum to the non-
tructural proteins nsp2 and nsp7–8, and monoclonal
ntibodies to GL and N proteins were used to detect the
xpression of specific proteins in the electroporated
HK-21 cells as previously described (van Dinten et al.,
996, 1997).
ntranasal inoculation of horses and sample
ollection
Two 2- to 3-year-old stallions [O (Thoroughbred) and E
Tennessee Walker) seronegative to EAV by serum neu-
ralization and Western immunoblotting assays were
oused in an isolation facility. Each stallion was intrana-
ally inoculated with 3.25 3 106 PFU/ml (2 3 106.25
CID50) of recombinant EAV030H virus that was delivered
n 4.0 ml of EMEM using a fenestrated catheter. The
tallions were monitored twice daily for 4 weeks for
linical manifestations of EVA. Whole blood for hematol-
gy [in buffered sodium citrate (Monojet) and thrombin
oya bean trypsin (Becton Dickinson) anticoagulants]
rom both stallions were collected at 0, 2, 4, 6, 8, 10, 12,
nd 14 days p.i. These samples were used for complete
lood counts (CBC), differential counts, and coagulation
rofiles [prothrombin time (PT), partial thromboplastin
ime (PTT), and fibrinogen degradation products (FDP)].
lood for virus isolation from plasma (heparin anticoag-
lant) and serum were collected at 0, 2, 4, 6, 8, 10, 12,14,
1, 28, 35, and 42 days p.i.. Whole blood samples were
lso collected into VACCUTAINER CPT cell preparation
ubes (Becton Dickinson) for the separation of mononu-
lear cells for virus isolation and viral RNA extraction.
he nasopharyngeal regions of both stallions were thor-
ughly swabbed at 0, 2, 4, 6, 8, 10, 12, 14, 21, and 28 days
.i. using sterile gauze sponges at the end of a 64-cm-
ong stainless steel wire. The gauze swabs were re-
oved after collection and placed in 5 ml of transport
edium [EMEM, 2% FBS, 1% penicillin/streptomycin, 1% uentamicin, and 2% fungizone (Gibco BRL)]. Semen sam-
les were also collected from both stallions before and
fter infection (7, 14, 28, and 60 days p.i.).
irus isolation
Virus isolation was attempted from mononuclear cells,
lasma, serum, nasal swabs, and semen samples.
ononuclear cells were separated by centrifugation.
riefly, blood samples in VACCUTAINER CPT cell prepa-
ation tubes were centrifuged at room temperature (18–
5°C) at 1600 g (2800 rpm) for 7 min, and the cell
onolayer layer was collected and washed twice in
terile PBS. The final cell pellet was resuspended in 6.5
l of sterile PBS at ;1.5 3 107–3.0 3 107 cells/ml.
ndividual nasal swabs (gauze sponges) and transport
edium were transferred to the barrel of a 12-ml dispos-
ble syringe and expressed through 0.45-mm syringe
ilter (Millipore). Semen samples were pretreated by son-
cation and centrifugation at 1000 g for 10 min at 4°C to
ediment the spermatozoa. Virus isolation was at-
empted on RK-13 cells. Briefly, confluent monolayers
24-h old) of RK-13 cells in 12-well plates or in 25-cm2
lasks (for semen) were inoculated with serial 10-fold
ilutions (100–105 in duplicate) and overlaid with RK-13
owth medium containing 0.75% caboxymethyl cellulose.
he cells were incubated at 37°C for 8–9 days, and
laques were visualized by staining of the monolayer
ith crystal violet. A second passage was performed 4–5
ays after the initial passage. Virus isolates were con-
irmed as EAV by microneutralization assay using EAV-
pecific antiserum and neutralizing monoclonal antibod-
es.
icroneutralization assay
Serum neutralizing antibodies to EAV were detected
y microneutralization assay using EAV030H as the chal-
enge virus in the presence of 5% guinea pig comple-
ent, as previously described (Balasuriya et al., 1995).
ntibody titers were recorded as the reciprocal of the
ighest final dilution that provided $50% protection of
he RK-13 cell monolayer.
NA isolation
Viral RNA was directly isolated using the QIAmp Viral
NA isolation kit (QIAgen) from 140 ml of nasopharyngeal
wab filtrate, plasma, serum, and semen samples, as
reviously described (Balasuriya et al., 1999). Total RNA
as also isolated from 500 ml of whole blood and mono-
uclear cells (;1.5 3 107 cells) using the RNA STAT-50
S(Test Tel Inc.) according to the manufactures instruc-
ions. The purified RNA samples were stored at 280°C
ntil used.
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207CLONE-DERIVED EAV IS REPLICATION COMPETENTT nested-PCR and sequencing
ORF 5 and flanking portions of ORF 4 and ORF 6 of the
AV in the various samples (882 bp) were amplified by
everse transcriptase polymerase chain reaction (RT–
CR) using MuLV reverse transcriptase (Perkin–Elmer)
nd AmpliTaq DNA polymerase (Perkin–Elmer) enzymes,
s previously described (Balasuriya et al., 1995). The
xternal primers 11,978–11,998 (59CTA ACC CAG ATG
TA CAT ACC 39; antisense primer) and 11,023–11,043 (59
GG ACA AGA GGC ATC CTT AC 39; sense primer) were
sed for the first 35 cycles of PCR. A second round of
mplification (nested PCR) was performed with 10 ml of
he first round product with two internal primers at posi-
ions 11,940–11,961 (59 GAG TGG GAC GGA CAG AAT
AA G 39; antisense primer) and 11,080–111,001 (59 TTG
GG CTA TAG TTT ATG TTC 39; sense primer). The
eaction mixtures were cycled 40 times in the second
ound with the same thermal profiles as those described
reviously. Twenty microliters of the final product was
lectrphoresed on a 1% agarose gel and visualized by
thidium bromide staining.
Twelve nested PCR reactions (100 ml per reaction)
erived from each sample were pooled, gel purified, and
oth sense and non-sense strands were sequenced with
he PRISM Ready Reaction DyeDeoxy Terminator cycle
equencing kit (Applied Biosystem) primed by internal
equence-specific primers as previously described
Hedges et al., 1996, 1999).
The 901-bp segment containing an engineered marker
indIII restriction site in ORF 1b was RT-PCR amplified
7468–7487 antisense primer 59 AAG TGG AGC GGT ACA
GA TG 39; 6587–6607 sense primer 59 GAC CTG GAG
GT TGT GAT CG 39) from RNA purified from the first
issue culture passage of the 6 days p.i. nasal swab
stallion E) and 6 days p.i. mononuclear cells (stallion O).
he fragment was digested with HindIII (Boehringer
annheim GmbH) and subjected to electrophoresis on a
% agarose gel, and visualized by ethidium bromide
taining.
olecular cloning
ORF 5 and flanking portions of ORF 4 and ORF 6 of EAV
n the original 030H virus-infected cell culture fluid and
elected mononuclear cell samples (stallion O: 14 days
.i., stallion E: 8 days p.i.), and a single semen sample
stallion O: 7 days p.i.) were reverse transcribed and
ested-PCR amplified with Superscript II (Gibco BRL)
nd Pfu DNA polymerase (Stratagene) enzymes respec-
ively for cloning. First-strand DNA was synthesized with
ligo (dT) primers (Gibco BRL) and purified with Glass-
AX DNA isolation system after digestion with RNase H
nd T1 (Gibco BRL). The high-fidelity Pfu DNA polymer-
se was used for PCR amplification to reduce artifactual
ubstitutions (Smith et al., 1997). The first 35 cycles of
CR were performed using the same external primers as Bescribed above. The reactions were initially heated at
6°C for 45 s and each cycle of amplification consisted
f 45 s of denaturation at 96°C, 45 s of annealing at
0°C, and 2-min extension at 72°C. After 35 cycles, the
eactions were subjected to a 10-min final extension at
2°C. A second round of amplification was performed
ith 10 ml of the first-round product with the same two
nternal primers described above. The reaction mixtures
ere cycled 40 times in the second round with the same
hermal profiles as those described above for Pfu DNA
olymerase (Stratagene). Twelve different PCR reactions
100 ml/reaction) were carried out with each RNA sam-
le, and the reaction products were pooled and concen-
rated (Centricon 30; Amicon). The 882-bp fragment con-
aining ORF5 was agarose gel purified with a commer-
ial kit (Qiaquick; Qiagen) and was cloned into the
CR2.1-TOPO cloning vector according to the manufac-
urer’s instructions (TOPO TA Cloning; Invitrogen Corp.).
wenty clones from each sample were sequenced as
reviously described (Balasuriya et al., 1999; Hedges et
l., 1999). The estimated rate of misincorporations in RT
ested-PCR and cloning is 0.5 artifactual substitutions
er 768 bp [based on the error rate of retrovirus RT
nzymes (5.5 3 1024 substitutions/base pair/cycle) and
fu DNA polymerase (1.3 3 1026)].
equence analysis
Sequence data were analyzed with the Sequencher
.0 (Gene Codes Corp.) and HIBIO MacDNASIS pro ver-
ion 3.5 (Hitachi) software programs using a Macintosh
ower PC.
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